Fig. 5

The differences of biological features between high- and low-risk score groups. A The hallmarks of cancer enriched in low-risk score group. B The hallmarks of cancer enriched in high-risk score group. C The comparison of expression level of antigen presentation, immune-activation and immune-checkpoint gene sets between high- and low-risk score groups. D The comparison of immune score between high- and low-risk score groups. E The comparison of estimate score between high- and low-risk score groups. F The comparison of tumor purity between high- and low-risk score groups. G The comparison of stromal score between high- and low-risk score groups. H The correlation between PRS and activity of angiogenesis. I The correlation between PRS and activity of Pan-F-TBRS. J Abundance of 28 immune cells in TME. ***p < 0.001; **p < 0.01; *p < 0.05; ns: no significance